Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Targeting Obesity Management Through Gut Microbiota Modulation by Herbal Products: A Systematic Review Publisher Pubmed



Ejtahed HS1 ; Soroush AR1 ; Siadat SD2 ; Hoseinitavassol Z2 ; Larijani B3 ; Hasaniranjbar S1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Obesity and Eating Habits Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Department of Mycobacteriology and Pulmonary Research, Microbiology Research Center, Pasteur Institute of Iran, Tehran, Iran
  3. 3. Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran

Source: Complementary Therapies in Medicine Published:2019


Abstract

Objectives: The gut dysbiosis has been implicated as a mediator to obesity and its manipulation could be an appropriate approach to sustainable weight loss. In this systematic review, our primary objective was to assess the potential manipulation of gut microbiota by herbal products in obesity. Materials and methods: We did a comprehensive search in PubMed, Web of Science, Scopus and Cochrane databases for all clinical trials and animal studies exploring the effects of various herbal products on gut microbiota composition in obesity documented up to May 2017. Results: Our initial search yielded 2766 articles. After screening abstracts and full texts, 68 articles were included (55 animal studies and 13 clinical trials). The studies differed in their methodologies, type of interventions and intervention lengths. The weight loss was only reported in 23% of trials and in 64% of animal studies. An increasing tendency in Bifidobacterium species and butyrate-producing bacteria such as Faecalibacterium prausnitzii were observed after consuming non-digestible carbohydrates, although these changes did not always correlate with weight loss. Supplementation with high concentration of polyphenols reduced body weight gain in animal studies and inhibited growth of detrimental species such as Clostridia and Enterobacteria while the growth of Lactic acid bacteria and Akkermansia muciniphila is enriched. Conclusions: Alteration of gut microbiota after interventions has been affected by the baseline composition of gut microbiota. This systematic review shows that consumption of herbal products might have beneficial effects on restoring healthy gut microbiome besides body fat reduction. © 2018
Other Related Docs
9. The Effects of Medicinal Herbs on Gut Microbiota and Metabolic Factors in Obesity Models: A Systematic Review, Diabetes and Metabolic Syndrome: Clinical Research and Reviews (2022)
11. Multidimensional Perspective of Obesity; Prevention to Treatment, Journal of Diabetes and Metabolic Disorders (2021)
13. Our Little Friends With Big Roles: Alterations of the Gut Microbiota in Thyroid Disorders, Endocrine# Metabolic and Immune Disorders - Drug Targets (2020)
14. Gut Microbiota-Derived Metabolites in Obesity: A Systematic Review, Bioscience of Microbiota# Food and Health (2020)
17. The Effect of the L-Carnitine Supplementation on Obesity Indices: An Umbrella Meta-Analysis, International Journal for Vitamin and Nutrition Research (2025)
18. The Role of Intestinal Microbiota in Cognitive Disorders, Journal of Mazandaran University of Medical Sciences (2021)
23. Ethical Challenges in Conducting and the Clinical Application of Human Microbiome Research, Journal of Medical Ethics and History of Medicine (2023)
29. Gut Microbiota Composition in Obese and Normal Weight Adults in Iran, Journal of Mazandaran University of Medical Sciences (2021)
36. Gut Microbiota: A Perspective of Precision Medicine in Endocrine Disorders, Journal of Diabetes and Metabolic Disorders (2020)
38. Precision Medicine in Endocrinology Practice, Precision Medicine in Clinical Practice (2022)
40. Trimethylamine N-Oxide As a Potential Risk Factor for Non-Communicable Diseases: A Systematic Review, Endocrine# Metabolic and Immune Disorders - Drug Targets (2023)